MNKD Q2 2021 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena

MNKDMannKind Corporation

$813M

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$23M+54.0% YoY

Gross Profit

$13M57.4% margin

Operating Income

-$10M-44.1% margin

Net Income

-$36M-152.6% margin

EPS (Diluted)

$-0.14

QoQ Revenue Growth

+33.5%

Cash Flow

Operating Cash Flow

-$21M

Free Cash Flow

-$23M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$253M

Total Liabilities

$436M

Stockholders' Equity

-$184M

Cash & Equivalents

$63M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$23M	$15M	+54.0%
Gross Profit	$13M	$9M	+41.3%
Operating Income	-$10M	-$8M	-29.8%
Net Income	-$36M	-$10M	-246.5%

Revenue Segments

License And Service

$6M100%